Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Bioxytran Inc BIXT

Healthcare Biotechnology

Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with an intended application, which includes... see more

Add To Watchlist

Bullboard (OTCQB:BIXT)

View:

Post by whytestockson Jul 17, 2024 11:32am

Presenting on the Emerging Growth Conference 73 Day 2 on Jul

Just In: $BIXT Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now | BenzingaMIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media ...more

Post by whytestockson Jul 17, 2024 11:02am

Presenting on the Emerging Growth Conference 73 Day 2 on Jul

Just In: $BIXT Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register NowMIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal ...more

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Post by christopher707on Mar 15, 2024 10:58am

Bioxytran ($BIXT): Redefining Healthcare through Innovation

Bioxytran, Inc. ($BIXT) is spearheading biotechnological advancements with its innovative approach to drug development. This groundbreaking platform extends beyond virology, addressing unmet medical ...more

Post by christopher707on Mar 14, 2024 8:22am

Bioxytran's Innovative Approach to Drug Design

Bioxytran, Inc. ($BIXT) pioneers novel carbohydrate structures using AI to create rational drug designs. With a market cap of $19.53 million and 165.58 million outstanding shares, their leading ...more

Post by christopher707on Mar 12, 2024 11:07am

$BIXT: Pioneering AI-Driven Drug Design Innovations

Bioxytran, Inc. ($BIXT) stands at the forefront of biotechnology, leveraging artificial intelligence to revolutionise drug design. With a market cap of $19.04 million and 165.58 million outstanding ...more

Post by christopher707on Mar 11, 2024 8:00am

$BIXT Market Impact and Transformative Solutions Journey

Bioxytran ($BIXT) stands out with a market cap of $18.81 million and 165.58 million outstanding shares. Focused on glycovirology, hypoxia, and degenerative diseases, their innovative carbohydrate drug ...more

Post by christopher707on Mar 08, 2024 7:04am

$BIXT:Revolutionising Healthcare with Cutting-Edge Solutions

In the ever-evolving landscape of healthcare, Bioxytran stands out with a market cap of $19.87 million. As an OTC-listed company under the symbol $BIXT, it boasts 165.59 million outstanding shares ...more

Post by christopher707on Mar 07, 2024 8:04am

Bioxytran ($BIXT): Resilient Growth in Pharmaceuticals

With a market cap of $19.87 million and 165.59 million outstanding shares, Bioxytran ($BIXT) is a force in pharmaceuticals. Averaging a 30-day volume of 62,545 and boasting a 52-week range of $0.071 ...more

Post by lelianicruzon Mar 05, 2024 10:34am

$BIXT : A Promising Player in Pharmaceuticals

With a market cap of $18.4M and a current price of $0.1113, Bioxytran ( $BIXT ) stands out as a significant contender in the pharmaceutical sector. Their focus on addressing critical medical ...more

Post by amritadaniqueon Oct 27, 2023 8:02am

Bioxytran, Inc. ($BIXT): Leading Healthcare Innovation!

Bioxytran, Inc. ($BIXT) boasts a market capitalization of $21.74 million and a strong 30-day average volume of 117,188, underscoring its presence in the healthcare landscape. As a biotech pioneer ...more

Post by amritadaniqueon Oct 26, 2023 8:58am

"$BIXT Valuation Highlights Promising Biotech Potential"

The present market capitalization of Bioxytran, Inc. ($BIXT) stands at $23.09 million, reflecting its promising potential in the biotech industry. This valuation underscores the company's ...more

Post by amritadaniqueon Oct 25, 2023 10:00am

$BIXT: Transforming Healthcare with Innovation

Bioxytran, Inc. ($BIXT) is a leading force in healthcare innovation, with a remarkable market capitalization exceeding $24.5 million and solid support from over 144 million outstanding shares. Their ...more

Post by amritadaniqueon Oct 24, 2023 11:48am

Bioxytran: Leading Healthcare Innovation Efforts

With a market capitalization of over $24.4 million and a remarkable 144,355,355 outstanding shares, Bioxytran is making substantial strides in the biotech industry. Their focus on tackling critical ...more

(0)
•••

Post by PressReleaseon Oct 24, 2023 8:45am

New Press Release - Bioxytran Gets Broad Patent Coverage on 60+ Viruses

Claims cover method of treating a viral infection with a lectin-binding carbohydrate BOSTON, MASSACHUSETTS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral...read article.

Post by amritadaniqueon Oct 20, 2023 7:10am

$BIXT: Transforming Healthcare with Innovative Solutions

Bioxytran, Inc. ($BIXT) is a pioneering force in healthcare, focused on combating hypoxia with innovative pharmaceutical solutions. Their robust market capitalization, exceeding $24.5 million, and 144 ...more

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Bioxytran Inc BIXT

Bullboard (OTCQB:BIXT)

Presenting on the Emerging Growth Conference 73 Day 2 on Jul

Presenting on the Emerging Growth Conference 73 Day 2 on Jul

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

Bioxytran ($BIXT): Redefining Healthcare through Innovation

Bioxytran's Innovative Approach to Drug Design

$BIXT: Pioneering AI-Driven Drug Design Innovations

$BIXT Market Impact and Transformative Solutions Journey

$BIXT:Revolutionising Healthcare with Cutting-Edge Solutions

Bioxytran ($BIXT): Resilient Growth in Pharmaceuticals

$BIXT : A Promising Player in Pharmaceuticals

Bioxytran, Inc. ($BIXT): Leading Healthcare Innovation!

"$BIXT Valuation Highlights Promising Biotech Potential"

$BIXT: Transforming Healthcare with Innovation

Bioxytran: Leading Healthcare Innovation Efforts

New Press Release - Bioxytran Gets Broad Patent Coverage on 60+ Viruses

$BIXT: Transforming Healthcare with Innovative Solutions

Featured News Links

Discover Options Trading Strategies to Minimize your Tax Burden

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Bioxytran Inc BIXT

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (OTCQB:BIXT)

Featured News Links